SPARTANAT plans report on Axiostat ®

Following a meeting at ENFORCE TAC 2024, the SPARTANAT team showed great interest in our hemostatic products for the treatment of heavily bleeding wounds. After a very informative discussion, we provided SPARTANAT with the relevant material. At https://www.spartanat.com/ SPARTANAT now announces a more detailed presentation of the Axiostat® products. We are excited and looking forward […]